ROYAL BANK OF CANADA - RITTER PHARMACEUTICALS INC ownership

RITTER PHARMACEUTICALS INC's ticker is RTTR and the CUSIP is 767836307. A total of 18 filers reported holding RITTER PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of RITTER PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$02,200
+83.3%
0.00%
Q4 2019$01,2000.0%0.00%
Q3 2019$0
-100.0%
1,2000.0%0.00%
Q2 2019$1,0000.0%1,2000.0%0.00%
Q1 2019$1,0000.0%1,2000.0%0.00%
Q4 2018$1,000
-50.0%
1,2000.0%0.00%
Q3 2018$2,000
-33.3%
1,2000.0%0.00%
Q2 2018$3,0000.0%1,2000.0%0.00%
Q1 2018$3,0001,2000.00%
Other shareholders
RITTER PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 343,642$206,0000.04%
Alyeska Investment Group, L.P. 4,250,000$2,550,0000.04%
CenterStar Asset Management, LLC 9,395$6,0000.01%
ARMISTICE CAPITAL, LLC 50,771$30,0000.00%
Baker Brothers Advisors 279,999$168,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 500$00.00%
VANGUARD GROUP INC 56,210$34,0000.00%
UBS Group AG 4,540$3,0000.00%
WELLS FARGO & COMPANY/MN 1,100$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of RITTER PHARMACEUTICALS INC shareholders